Announcements Trials
Browse Landscape

Phase

Phase 2 256Phase 3 181Phase 1 90Phase 1/2 66Phase 2/3 20Phase NA 12Phase EARLY_PHASE1 6Phase 4 4

Status

Recruiting 2Terminated 1Completed 1

Sponsor Class

OTHER 3INDUSTRY 1

Study Type

Interventional 4

Sponsor

Cancer Type

Breast 3Head & Neck 1Gastrointestinal 1

Conditions

Breast Neoplasms 2Stomach Neoplasms 1Squamous Cell Carcinoma of Head and Neck 1Parkinson Disease 4, Autosomal Dominant Lewy Body 1Esophageal Neoplasms 1Breast Neoplasm Female 1

Interventions

Dexamethasone 13Saline Solution 8Bupivacaine 8Bevacizumab 8Tobacco Use Cessation Devices 7Specimen Handling 7Nivolumab 7Magnetic Resonance Spectroscopy 7Lenalidomide 7Fluorouracil 7pembrolizumab 6Rituximab 6Prednisone 6Letrozole 6Carboplatin 6Propofol 5Human Papillomavirus Recombinant Vaccine nonavalent 5trametinib 4lenvatinib 4dabrafenib 4cabozantinib 4anlotinib 4Trastuzumab 4Tamoxifen 4Standard of Care 4Sodium Chloride 4Ropivacaine 4Paclitaxel 4Immune Checkpoint Inhibitors 4Esomeprazole 4

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Phase 4 × Paclitaxel × 1 year × Clear all
NCT05183126 2026-03-06

Pharmacokinetic Study of Skeletal Muscle Area-based Paclitaxel Infusion in Patients With Cancer

University of Michigan Rogel Cancer Center

Phase 4 Recruiting
22 enrolled
BreastGastrointestinal

Breast Neoplasms, Esophageal Neoplasms, Stomach Neoplasms

NCT03096418 2026-01-16

Neoadjuvant Weekly Paclitaxel and Biomarkers of Therapy Response

University of Wisconsin, Madison

Phase 4 Recruiting
50 enrolled 12 charts
Breast

Breast Neoplasm Female

NCT02688803 2025-12-04

OTT15-04

Ottawa Hospital Research Institute

Phase 4 Terminated
2 enrolled 4 charts
Breast

Breast Neoplasms

NCT04489888 2025-06-19

MK-3475-B10

Merck Sharp & Dohme LLC

Phase 4 Completed
101 enrolled 14 charts
Head & Neck

Parkinson Disease 4, Autosomal Dominant Lewy Body, Squamous Cell Carcinoma of Head and Neck

Data powered by HemOnc (CC BY 4.0) Colophon âš¡